Skip to main content
logo
Hansa Biopharma AB (publ) (STO:HNSA)
Sweden flag Sweden · Delayed Price · Currency is SEK
37.82
-1.52 (-3.86%)
Nov 2, 2026, 5:24 PM CET

Hansa Biopharma AB Ratios and Metrics

Millions SEK. Fiscal year is Jan - Dec.

Total Valuation

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Nov '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Market Capitalization
3,8493,4972,6581,3742,5813,949
Market Cap Growth
9.75%31.53%93.47%-46.77%-34.64%-63.06%
Enterprise Value
4,3304,1683,0641,3962,1572,963
Last Close Price
39.3434.3639.2026.2049.2288.80

Price Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Nov '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PS Ratio
21.1315.7315.5210.2516.70116.57
PB Ratio
--39.29-4.51-8.184.285.21
P/TBV Ratio
----4.475.42

EV Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Nov '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
EV/Sales Ratio
23.6718.7517.8910.4113.9687.45

Financial Efficiency

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Nov '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Debt / Equity Ratio
-1.99-10.55-1.83-5.161.310.05
Net Debt / Equity Ratio
-0.92-2.67-1.14-0.80-1.17-1.13
Net Debt / EBITDA Ratio
-0.84-0.46-1.07-0.171.231.59
Net Debt / FCF Ratio
-0.84-0.43-1.00-0.181.391.77
Asset Turnover
0.200.230.190.100.110.03
Inventory Turnover
14.8819.1240.5350.8063.3490.74
Quick Ratio
1.231.881.762.575.915.33
Current Ratio
1.251.941.832.666.065.50
Return on Equity (ROE)
----382.37%-89.84%-54.84%
Return on Assets (ROA)
-37.83%-33.20%-43.45%-36.55%-26.67%-27.56%
Return on Capital Employed (ROCE)
-111.80%-69.10%-116.00%-113.50%-40.50%-64.10%

Yields

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Nov '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Earnings Yield
-20.46%-15.28%-30.37%-60.53%-23.68%-13.88%
FCF Yield
-14.23%-15.71%-25.39%-55.02%-19.61%-12.25%
Buyback Yield / Dilution
-42.70%-29.23%-19.59%-16.95%-1.01%-5.45%